SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Interestingly, a similar approach using defective Zinc Finger Nucleases fused to a transcriptional activator targeted to the Scn1a promoter has also been shown to be effective in a mouse model of Dravet syndrome.